Area of research
Infectious Diseases · Molecular Biology
Research interest
Research focused on Immunology and Immune system, with related work in Community-acquired pneumonia, Pneumonia, Streptococcus pneumoniae. Notable publications include 'COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registry', 'COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma', and 'Mucosal-Associated Invariant T (MAIT) Cells Are Highly Activated and Functionally Impaired in COVID-19 Patients'.
Community-acquired pneumonia in diabetic patients is characterised by a distinct pathogen spectrum and enhanced inflammation: results from CAPNETZ, a prospective observational cohort study
Resurgence of common respiratory viruses in patients with community-acquired pneumonia (CAP)—A prospective multicenter study
IL-33 controls IL-22-dependent antibacterial defense by modulating the microbiota
Receptor transfer between immune cells by autoantibody-enhanced, CD32-driven trogocytosis is hijacked by HIV-1 to infect resting CD4 T cells
Comparison of clinical outcomes in hospitalized patients with COVID-19 or non-COVID-19 community-acquired pneumonia in a prospective observational cohort study
Tixagevimab/Cilgavimab for COVID-19 Pre-Exposure Prophylaxis in Hematologic Patients—A Tailored Approach Based on SARS-CoV-2 Vaccine Response
Autoantibody-Enhanced, CD32-Driven Trogocytosis Creates Functional Plasticity of Immune Cells and is Hijacked by HIV-1 to Infect Resting CD4 T Cells
Correction to: Severe Dysbiosis and Specific <i>Haemophilus</i> and <i>Neisseria</i> Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients
COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma
Mucosal-Associated Invariant T (MAIT) Cells Are Highly Activated and Functionally Impaired in COVID-19 Patients
Severe Dysbiosis and Specific <i>Haemophilus</i> and <i>Neisseria</i> Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients
Evaluation of a multiplex PCR screening approach to identify community-acquired bacterial co-infections in COVID-19: a multicenter prospective cohort study of the German competence network of community-acquired pneumonia (CAPNETZ)
Pre-medication with oral anticoagulants is associated with better outcomes in a large multinational COVID-19 cohort with cardiovascular comorbidities
COVID-19 severity and complications associated with low diversity, dysbiosis and predictive metagenome features of the oropharyngeal microbiome.
COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registry
Efficacy and Safety of Switching to Dolutegravir With Boosted Darunavir in Virologically Suppressed Adults With HIV-1: A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: The DUALIS Study
No SARS-CoV-2 detection in the German CAPNETZ cohort of community acquired pneumonia before COVID-19 peak in March 2020
A diagnostic algorithm for detection of urinary tract infections in hospitalized patients with bacteriuria: The “Triple F” approach supported by Procalcitonin and paired blood and urine cultures